SEC 13F Intelligence

ONCONOVA THERAPEUTICS INC

CUSIP 68232V116

Onconova Therapeutics Inc has 6 institutional holders in Filings Flow’s 13F database, together reporting 13.2K shares worth $2,000 as of Q2 2021. The largest reported holders are Susquehanna International Group, LLP, Two Sigma Securities, LLC, and Citadel Advisors LLC.

Institutional Holders
2
Q2 2021
Reported Value
$2,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
5

Ownership Trend

Institutional holders
Q4 ’18: 5Q4 ’18Q1 ’19: 6Q1 ’19Q2 ’19: 6Q2 ’19Q3 ’19: 6Q3 ’19Q2 ’21: 2Q2 ’21filingsflow.com
Total reported value
Q4 ’18: $47,000Q4 ’18Q1 ’19: $121,000Q1 ’19Q2 ’19: $266,000Q2 ’19Q3 ’19: $50,000Q3 ’19Q2 ’21: $2,000Q2 ’21filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
TWO SIGMA SECURITIES, LLC$861M AUM0.00%$4,00012.8KQ1 2021OLDER
SUSQUEHANNA INTERNATIONAL GROUP, LLP$893.3B AUM0.00%$6,00058.7KQ4 2020OLDER
CITADEL ADVISORS LLC$618.5B AUM0.00%$3,00032.0KQ4 2020OLDER
UBS Group AG$666.3B AUM0.00%$2,00013.2KQ2 2021

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.